Ghadir Saeed EL-HOUSSEINY, Mohammad Mabrouk ABOULWAFA, Nadia Abdelhaleim HASSOUNA

Cytotoxic activities of some Pseudomonas aeruginosa isolates: possible mechanisms and approaches for inhibition

The cytotoxicity of 6 highly cytotoxic Pseudomonas aeruginosa isolates was tested against Vero cells. Cytotoxicity was found to be cell-associated, high cytotoxicity was observed at a multiplicity of infection of 200:1, and this activity gradually decreased as the bacterial count decreased. This cytotoxicity caused rounding and detachment of the Vero monolayer as early as 1 h after infection. Moreover, viable metabolically active bacteria were necessary for Vero cell killing. These results imply that one or more of the type III secretion system effector proteins (ExoU, ExoS, ExoT, or ExoY) were responsible for the observed cytotoxic effects. This cytotoxicity was affected by changes in pH and temperature and was associated with high adherence but poor invasion levels. The isolates P127, P139, P205, and P217 exhibited their cytotoxic effect within short infection periods (2 h), and MAFP (an ExoU inhibitor) caused a dose-dependent reduction of this effect, implying that these cytotoxicities were due to the effector ExoU. On the other hand, P206 and P231 caused loss of Vero cell viability only after prolonged incubation periods (10 h) and were unaffected by both MAFP and E216-5138 (ExoS inhibitor), indicating that ExoT may be the effector responsible for the observed cytotoxic effects. Several compounds were tested to inhibit bacterial cytotoxicity. Mannose of the tested antiadherents and poloxamer 407 of the tested pharmaceutical excipients had the greatest inhibitory effects. Concerning the metal ions, Fe3+ and Zn2+ nearly abolished the observed cytotoxic effects.

Anahtar Kelimeler:

Key words: Cytotoxicity, ExoU, ExoS, TTSS, Pseudomonas aeruginosa, Vero cells

Cytotoxic activities of some Pseudomonas aeruginosa isolates: possible mechanisms and approaches for inhibition

Keywords:

Key words: Cytotoxicity, ExoU, ExoS, TTSS, Pseudomonas aeruginosa, Vero cells,

PDF

___

Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2: 1051–60, 2000.
Lee VT, Smith RS, Tummler B et al. Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect Immun 73: 1695–705, 2005.
Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 12: 61–6, 2009.
El-Housseiny G, Aboulwafa MM, Hassouna NA. Adherence, invasion and cytotoxicity of some bacterial pathogens. J Am Sci 6: 260–8, 2010.
Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 182: 16–9, 1989.
Plotkowski MC, Saliba AM, Pereira SHM et al. Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infect Immun 62: 5456–63, 1994.
Prasad KN, Dhole TN, Ayyagari A. Adherence, invasion and cytotoxin assay of Campylobacter jejuni in HeLa and HEp-2 cells. J Diarrhoeal Dis Res 14: 255–9, 1996.
Apodaca G, Bomsel M, Lindstedt R et al. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun 63: 1541–51, 1995.
Evans DJ, Frank DW, Finck-Barbancon V et al. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun 66: 1453–9, 1998.
Saliba AM, de Assis MC, Nishi R et al. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect 8: 450–9, 2006.
Arnoldo A, Curak J, Kittanakom S et al. Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen. PLoS Genet 4: e1000005, 200
Sugarman B, Epps LR, Stenback WA. Zinc and bacterial adherence. Infect Immun 37: 1191–9, 1982.
Olson JC, McGuffie EM, Frank DW. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect Immun 65: 248– 56, 1997.
Finck-Barbancon V, Goranson J, Zhu L et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25: 547–57, 1997.
Saliba AM, Filloux A, Ball G et al. Type III secretion-mediated killing of endothelial cells by Pseudomonas aeruginosa. Microb Pathogenesis 33: 153–66, 2002.
Jendrossek V, Grassme H, Mueller I et al. Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases. Infect Immun 69: 2675–83, 200
Rajan S, Cacalano G, Bryan R et al. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells - analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Resp Cell Mol 23: 304–12, 2000.
Grant MM, Niederman MS, Poehlman MA et al. Characterization of Pseudomonas aeruginosa adherence to cultured hamster tracheal epithelial cells. Am J Resp Cell Mol 5: 563–70, 1991.
Sato H, Frank DW, Hillard CJ et al. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 22: 2959–69, 2003.
Yahr TL, Hovey AK, Kulich SM et al. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme-S structural gene. J Bacteriol 177: 1169–78, 1995.
Dacheux D, Epaulard O, de Groot A et al. Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect Immun 70: 3973–7, 2002.
Rietsch A, Wolfgang MC, Mekalanos JJ. Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa. Infect Immun 72: 1383–90, 2004.
Xiao Y. Regulation of Type III Secretion System in Pseudomonas syringae, PhD, Kansas State University, Manhattan, Kansas, 200 Sundin C. Type III Secretion Mediated Translocation of Effector Exoenzymes by Pseudomonas aeruginosa, PhD, Umeå University, Umeå, Sweden, 2003.
Hornef MW, Roggenkamp A, Geiger AM et al. Triggering the ExoS regulon of Pseudomonas aeruginosa: a GFP-reporter analysis of exoenzyme (Exo) S, ExoT and ExoU synthesis. Microb Pathogenesis 29: 329–43, 2000.
Vallis AJ, Finck-Barbançon V, Yahr TL et al. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67: 2040–4, 1999.
Gendrin C, Contreras-Martel C, Bouillot S et al. Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa. PLoS Pathog 8: e1002637, 20
Shafikhani SH, Morales C, Engel J. The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells. Cell Microbiol 10: 994–1007, 2008.
Maman Y, Nir-Paz R, Louzoun Y. Bacteria modulate the CD8+ T cell epitope repertoire of host cytosol-exposed proteins to manipulate the host immune response. PLoS Comput Biol 7: e1002220, 2011.
Phillips RM, Six DA, Dennis EA et al. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A(2) inhibitors. J Biol Chem 278: 41326–32, 2003.
Hafez MM. Studies Concerning Microbial Adherence to Mammalian Cells, PhD, Ain Shams University, Cairo, Egypt, 200 Yurdusev N. In vitro model for the study of Listeria and Salmonella adherence to intestinal epithelial cells. Turk J Biol 25: 25–35, 2001.
Thomas R, Brooks T. Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens. J Med Microbiol 53: 833–40, 2004.
Barghouthi S, Guerdoud LM, Speert DP. Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells. Am J Resp Crit Care 154: 1788–93, 1996.
Alksne LE, Projan SJ. Bacterial virulence as a target for antimicrobial chemotherapy. Curr Opin Biotech 11: 625–36, 2000.
Kocabıyık S, Ergin E. Biochemical characterization of elastase from Pseudomonas aeruginosa SES 938-1. Turk J Biol 22: 181– 8, 19 Mittal R, Sharma S, Chhibber S et al. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci 15: 731–41, 2008.
Crane JK, Naeher TM, Shulgina I et al. Effect of zinc in enteropathogenic Escherichia coli infection. Infect Immun 75: 5974–84, 2007.